These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 21034789)
1. Psychopharmacology in autism: an update. Canitano R; Scandurra V Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):18-28. PubMed ID: 21034789 [TBL] [Abstract][Full Text] [Related]
2. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. Baghdadli A; Gonnier V; Aussilloux C Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786 [TBL] [Abstract][Full Text] [Related]
3. An update on pharmacologic treatments for autism spectrum disorders. King BH; Bostic JQ Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):161-75. PubMed ID: 16321729 [TBL] [Abstract][Full Text] [Related]
4. Risperidone: a potential treatment for autism. Posey DJ; McDougle CJ Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. Findling RL J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147 [TBL] [Abstract][Full Text] [Related]
6. Role of risperidone in children with autism spectrum disorder. Chavez B; Chavez-Brown M; Rey JA Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811 [TBL] [Abstract][Full Text] [Related]
7. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197 [TBL] [Abstract][Full Text] [Related]
9. Risperidone use in the treatment of behavioral symptoms in children with autism. West L; Waldrop J Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292 [TBL] [Abstract][Full Text] [Related]
10. Psychopharmacology of autism spectrum disorders. Kaplan G; McCracken JT Pediatr Clin North Am; 2012 Feb; 59(1):175-87, xii. PubMed ID: 22284801 [TBL] [Abstract][Full Text] [Related]
12. [Management of children with autism spectrum disorders]. Gadia CA; Tuchman RF Rev Neurol; 2003 Jan 16-31; 36(2):166-73. PubMed ID: 12589605 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment for the core deficits and associated symptoms of autism in children. West L; Waldrop J; Brunssen S J Pediatr Health Care; 2009; 23(2):75-89. PubMed ID: 19232924 [TBL] [Abstract][Full Text] [Related]
14. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present. Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522 [TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883 [TBL] [Abstract][Full Text] [Related]
16. Use of atypical antipsychotics in the treatment of autistic disorder. Stachnik JM; Nunn-Thompson C Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666 [TBL] [Abstract][Full Text] [Related]